Lv4
446 积分 2023-06-15 加入
CAR-T therapy in solid tumors
1天前
待确认
Multifaceted roles of APOE in Alzheimer disease
15天前
已完结
C‐CAR066, a novel fully human anti‐CD20 CAR‐T therapy for relapsed or refractory large B‐cell lymphoma after failure of anti‐CD19 CAR‐T therapy: A phase I clinical study
1个月前
已完结
Long-term outcomes of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma: Updated results of the RELIANCE study
1个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
1个月前
已完结
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
1个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
5个月前
已完结
The tyranny of non-inferiority trials
6个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
7个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
7个月前
已完结
皖公网安备34019202002308
